These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25889208)

  • 1. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
    Johnson B; Richert T
    J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
    Johnson B; Richert T
    Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
    Johnson B; Richert T
    J Addict Dis; 2015; 34(1):1-17. PubMed ID: 25496247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
    Johnson B; Richert T
    J Subst Abuse Treat; 2015 Jul; 54():50-5. PubMed ID: 25744650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
    Schulte B; Schmidt CS; Strada L; Götzke C; Hiller P; Fischer B; Reimer J
    Int J Drug Policy; 2016 Mar; 29():57-65. PubMed ID: 26818083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.
    Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R
    Drug Alcohol Rev; 2011 Nov; 30(6):613-20. PubMed ID: 21355939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid substitution therapy: Lowering the treatment thresholds.
    Kourounis G; Richards BD; Kyprianou E; Symeonidou E; Malliori MM; Samartzis L
    Drug Alcohol Depend; 2016 Apr; 161():1-8. PubMed ID: 26832931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
    Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
    Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
    Longman C; Lintzeris N; Temple-Smith M; Gilchrist G
    Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
    Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.